Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1980 1
1993 1
1994 1
1995 1
1996 1
1997 1
1999 1
2000 3
2001 2
2002 4
2004 1
2005 7
2006 5
2007 3
2008 4
2009 6
2010 8
2011 2
2012 13
2013 23
2014 18
2015 19
2016 24
2017 23
2018 22
2019 16
2020 29
2021 30
2022 34
2023 24
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Results by year

Filters applied: . Clear all
Page 1
Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Abraham MB, de Bock M, Smith GJ, Dart J, Fairchild JM, King BR, Ambler GR, Cameron FJ, McAuley SA, Keech AC, Jenkins A, Davis EA, O'Neal DN, Jones TW; Australian Juvenile Diabetes Research Fund Closed-Loop Research group. Abraham MB, et al. JAMA Pediatr. 2021 Dec 1;175(12):1227-1235. doi: 10.1001/jamapediatrics.2021.3965. JAMA Pediatr. 2021. PMID: 34633418 Free PMC article. Clinical Trial.
Distal technologies and type 1 diabetes management.
Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA. Duke DC, et al. Among authors: speight j. Lancet Diabetes Endocrinol. 2018 Feb;6(2):143-156. doi: 10.1016/S2213-8587(17)30260-7. Epub 2017 Aug 31. Lancet Diabetes Endocrinol. 2018. PMID: 28867311 Review.
Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations.
Speight J, Holmes-Truscott E, Garza M, Scibilia R, Wagner S, Kato A, Pedrero V, Deschênes S, Guzman SJ, Joiner KL, Liu S, Willaing I, Babbott KM, Cleal B, Dickinson JK, Halliday JA, Morrissey EC, Nefs G, O'Donnell S, Serlachius A, Winterdijk P, Alzubaidi H, Arifin B, Cambron-Kopco L, Santa Ana C, Davidsen E, de Groot M, de Wit M, Deroze P, Haack S, Holt RIG, Jensen W, Khunti K, Kragelund Nielsen K, Lathia T, Lee CJ, McNulty B, Naranjo D, Pearl RL, Prinjha S, Puhl RM, Sabidi A, Selvan C, Sethi J, Seyam M, Sturt J, Subramaniam M, Terkildsen Maindal H, Valentine V, Vallis M, Skinner TC. Speight J, et al. Lancet Diabetes Endocrinol. 2024 Jan;12(1):61-82. doi: 10.1016/S2213-8587(23)00347-9. Lancet Diabetes Endocrinol. 2024. PMID: 38128969 Review.
299 results